Accumulating research evidence suggests that nutrition might be implicated in the risk of
development and in the management of autoimmune disease, including rheumatoid arthritis …

Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-
EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods …

New evidence for the treatment of rheumatoid arthritis (RA) has emerged during the last
year. Specifically, updated guidelines on pharmacological and non-pharmacological …

Objectives To develop EULAR recommendations for screening and prophylaxis of chronic
and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases …

The US Food and Drug Administration (FDA) has recently added a new 'black box
warning'on all currently approved Janus kinase (JAK) inhibitors indicated for the treatment of …

Objective To develop evidence-based recommendations for the non-pharmacological
management of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). Methods …

Objective In 2011, the American College of Rheumatology (ACR) and EULAR endorsed
provisional criteria for remission in rheumatoid arthritis (RA), both Boolean-based and index …

Objectives Fatigue is prevalent in people with inflammatory rheumatic and musculoskeletal
diseases (I-RMDs) and recognised as one of the most challenging symptoms to manage …

Elderly-onset rheumatoid arthritis (EORA) is prevalent among older patients, and its
incidence is increasing due to aging societies. However, differentiating between EORA and …

Objective The inflammatory arthritides (IAs) make up a significant proportion of conditions
followed up in rheumatology clinics. These patients require regular monitoring, but this is …